Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(14%)
Results Posted
150%(6 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
4
57%
Ph phase_2
3
43%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
3(42.9%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (42.9%)
N/A4 (57.1%)

Trials by Status

completed457%
terminated229%
recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7